Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Inflammasome activation in patients with Kaposi sarcoma herpesvirus–associated diseases

Silvia Lucena Lage, Ramya Ramaswami, Joseph M. Rocco, Adam Rupert, David A. Davis, Kathryn Lurain, Maura Manion, Denise Whitby, Robert Yarchoan, Irini Sereti

Blood (2024) 144 (14): 1496–1507.

https://doi.org/10.1182/blood.2024024144

Published: 2024

Includes: Supplemental data

Journal Articles

Treatment Outcomes and Prognostic Factors in 40 Patients with Primary Effusion Lymphoma

Krithika Shanmugasundaram, Ramya Ramaswami, Anaida Widell, Ralph Mangusan, Elaine S. Jaffe, Stefania Pittaluga, Hao-Wei Wang, Vickie Ann Marshall, Denise Whitby, Richard F. Little, Mark N. Polizzotto, Thomas S. Uldrick, Robert Yarchoan, Kathryn A. Lurain

Blood (2021) 138 (Supplement 1): 1437.

https://doi.org/10.1182/blood-2021-151409

Published: 2021

Journal Articles

Phase I Study of Lenalidomide Combined with Dose-Adjusted EPOCH and Rituximab (EPOCH-R 2 ) in Primary Effusion Lymphoma in Participants with or without HIV (NCT02911142)

Kathryn Lurain, MDMPH, Ramya Ramaswami, MBBS,MPH, Anaida Widell, RN, Irene Ekwede, RN, Ralph Mangusan, DNP, CRNP, Jomy George, PharmD, Elaine S. Jaffe, MD, Stefania Pittaluga, MD PhD, Maryalice Stetler-Stevenson, MD PhD, Mark Roth, MD, Constance M. Yuan, MD PhD, Hao-Wei Wang, MD PhD, Vickie Ann Marshall, Denise Whitby, Thomas S. Uldrick, MD MS, Robert Yarchoan, MD

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-137188

Published: 2020

Journal Articles

Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus–associated multicentric Castleman disease

Ramya Ramaswami, Kathryn Lurain, Cody J. Peer, Anna Serquiña, Victoria Wang, Anaida Widell, Priscila Goncalves, Seth M. Steinberg, Vickie Marshall, Jomy George, William D. Figg, Denise Whitby, Joseph Ziegelbauer, Thomas S. Uldrick, Robert Yarchoan

Blood (2020) 135 (25): 2316–2319.

https://doi.org/10.1182/blood.2019004602

Published: 2020

Includes: Supplemental data

Journal Articles

Phase I/II Study of Lenalidomide Combined with DA-EPOCH and Rituximab (DA-EPOCH-R 2 ) in Primary Effusion Lymphoma in Patients with or without HIV

Kathryn Lurain, MDMPH, Ramya Ramaswami, MBBS,MPH, Anaida Widell, RN, Irene Ekwede, RN, Jomy George, PharmD, Maryalice Stetler-Stevenson, MD PhD, Mark Raffeld, MD, Constance M. Yuan, MD PhD, Joseph Ziegelbauer, PhD, Frank Maldarelli, MD PhD, William D. Figg, PharmD, Cody Peer, PhD, Seth M. Steinberg, PhD, Denise Whitby, Thomas S. Uldrick, MD MS, Robert Yarchoan, MD

Blood (2019) 134 (Supplement_1): 4096.

https://doi.org/10.1182/blood-2019-122070

Published: 2019

Journal Articles

Viral, immunologic, and clinical features of primary effusion lymphoma

Kathryn Lurain, Mark N. Polizzotto, Karen Aleman, Manisha Bhutani, Kathleen M. Wyvill, Priscila H. Gonçalves, Ramya Ramaswami, Vickie Ann Marshall, Wendell Miley, Seth M. Steinberg, Richard F. Little, Wyndham Wilson, Armando C. Filie, Stefania Pittaluga, Elaine S. Jaffe, Denise Whitby, Robert Yarchoan, Thomas S. Uldrick

Blood (2019) 133 (16): 1753–1761.

https://doi.org/10.1182/blood-2019-01-893339

Published: 2019

Journal Articles

IL-13 Expression Characterizes Effusions Associated with Primary Effusion Lymphoma but Not Other Disorders Caused By Kaposi Sarcoma Herpesvirus (KSHV)

Ramya Ramaswami, MBBS, MPH, Kathryn Lurain, MD MPH, Vickie Marshall, Nazzarena Labo, MD PhD, Anaida Widell, Matthew Lindsley, Mark N. Polizzotto, Denise Whitby, Thomas S. Uldrick, MD MS, Robert Yarchoan, MD

Blood (2018) 132 (Supplement 1): 4137.

https://doi.org/10.1182/blood-2018-99-117668

Published: 2018

Journal Articles

Pilot Study of Tocilizumab in Patients with HIV and Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease

Ramya Ramaswami, MBBS, MPH, Kathryn Lurain, MD MPH, Anaida Widell, Mark N. Polizzotto, Priscila H. Goncalves, MD, Matthew Lindsley, Seth M. Steinberg, PhD, Denise Whitby, Thomas S. Uldrick, MD MS, Robert Yarchoan, MD

Blood (2018) 132 (Supplement 1): 2894.

https://doi.org/10.1182/blood-2018-99-113119

Published: 2018

Journal Articles

Targeting HGF/c-MET induces cell cycle arrest, DNA damage, and apoptosis for primary effusion lymphoma

Lu Dai, Jimena Trillo-Tinoco, Yueyu Cao, Karlie Bonstaff, Lisa Doyle, Luis Del Valle, Denise Whitby, Chris Parsons, Krzysztof Reiss, Jovanny Zabaleta, Zhiqiang Qin

Blood (2015) 126 (26): 2821–2831.

https://doi.org/10.1182/blood-2015-07-658823

Published: 2015

Includes: Supplemental data

Journal Articles

Inflammatory Cytokines, Hyperferritinemia and IgE Are Prognostic in Patients with KSHV-Associated Lymphomas Treated with Curative Intent Therapy

Thomas S. Uldrick, MD MS, Manisha Bhutani, MD, Mark N. Polizzotto, MBBS, BMedSc, Karen O. Aleman, RN, Kathleen M. Wyvill, RN, Priscila H. Goncalves, MD, Stefania Pittaluga, MD PhD, Armando Filie, MD, Vickie Marshall, PhD, Adam W Rupert, Giovanna Tosato, MD, Denise Whitby, PhD, Richard F Little, MPH, MD, Seth M. Steinberg, PhD, Robert Yarchoan, MD

Blood (2014) 124 (21): 3001.

https://doi.org/10.1182/blood.V124.21.3001.3001

Published: 2014

Journal Articles

Pomalidomide Induces Expansion of Activated and Central Memory CD4+ and CD8+ T Cells in Vivo in Patients with and without HIV Infection

Mark N. Polizzotto, MBBS, FRACP, FRCPA, Irini Sereti, MD, Thomas S. Uldrick, MD MS, Kathleen M. Wyvill, RN, Stig M. R. Jensen, PhD, Amrit Singh, BSc, Stephen B. Kovacs, BSc, Karen O. Aleman, RN, Vickie Marshall, PhD, Denise Whitby, PhD, Frank Maldarelli, MD PhD, Seth M. Steinberg, PhD, Jerome B. Zeldis, MD PhD, Robert Yarchoan, MD

Blood (2014) 124 (21): 4128.

https://doi.org/10.1182/blood.V124.21.4128.4128

Published: 2014

Journal Articles

Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease

Thomas S. Uldrick, Mark N. Polizzotto, Karen Aleman, Kathleen M. Wyvill, Vickie Marshall, Denise Whitby, Victoria Wang, Stefania Pittaluga, Deirdre O’Mahony, Seth M. Steinberg, Richard F. Little, Robert Yarchoan

Blood (2014) 124 (24): 3544–3552.

https://doi.org/10.1182/blood-2014-07-586800

Published: 2014

Includes: Supplemental data

Journal Articles

Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease

Mark N. Polizzotto, Thomas S. Uldrick, Victoria Wang, Karen Aleman, Kathleen M. Wyvill, Vickie Marshall, Stefania Pittaluga, Deirdre O’Mahony, Denise Whitby, Giovanna Tosato, Seth M. Steinberg, Richard F. Little, Robert Yarchoan

Blood (2013) 122 (26): 4189–4198.

https://doi.org/10.1182/blood-2013-08-519959

Published: 2013

Includes: Supplemental data

Journal Articles

Clinical, Immunologic, and Virologic Findings in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Lymphomas Suggest KSHV-Associated Inflammatory Syndromes Contribute to Symptoms and Disease Pathogenesis.

Thomas S Uldrick, MD, MS, Mark N Polizzotto, MBBS, BMedSc, Armando Filie, MD, Karen Aleman, RN, Kathleen M Wyvill, RN, Richard F Little, MD, MPH, Seth M. Steinberg, PhD, Elaine S Jaffe, MD, Denise Whitby, PhD, Stefania Pittaluga, Robert Yarchoan, MD

Blood (2012) 120 (21): 2708.

https://doi.org/10.1182/blood.V120.21.2708.2708

Published: 2012

Journal Articles

EBV Copy Number Variation in Twins Discordant for Young Adult Hodgkin Lymphoma

Wendy Cozen, DO, MPH, Amie Hwang, M.P.H., Vickie Marshall, Ph.D., Thomas M Mack, M.D., M.P.H., Denise Whitby, PhD

Blood (2011) 118 (21): 2631.

https://doi.org/10.1182/blood.V118.21.2631.2631

Published: 2011

Journal Articles

Distinct Human and Viral Interleukin-6 Profiles and Other Viral and Immunologic Abnormalities In KSHV-Associated Multicentric Castleman Disease: Relationship with Disease Activity and Individual Disease Manifestations

Mark N Polizzotto, MBBS, BMedSc, Thomas S Uldrick, MD, MS, Victoria Wang, PhD, Karen Aleman, RN, Kathleen M Wyvill, RN, Vickie Marshall, PhD, Stefania Pittaluga, MD, PhD, Deirdre O'Mahony, MBBS, Denise Whitby, PhD, Giovanna Tosato, PhD, Seth M. Steinberg, PhD, Richard F Little, MD, MPH, Robert Yarchoan, MD

Blood (2011) 118 (21): 1573.

https://doi.org/10.1182/blood.V118.21.1573.1573

Published: 2011

Journal Articles

High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy

Thomas S. Uldrick, Mark N. Polizzotto, Karen Aleman, Deirdre O'Mahony, Kathleen M. Wyvill, Victoria Wang, Vickie Marshall, Stefania Pittaluga, Seth M. Steinberg, Giovanna Tosato, Denise Whitby, Richard F. Little, Robert Yarchoan

Blood (2011) 117 (26): 6977–6986.

https://doi.org/10.1182/blood-2010-11-317610

Published: 2011

Includes: Supplemental data

Journal Articles

Early Results of a Clinical Trial Using Targeted Oncolytic Virotherapy in Kaposi Sarcoma Herpes Virus (KSHV) Associated Multicentric Castleman’s Disease (MCD).

Deirdre O’Mahony, MD, Wendy Bernstein, MD, Kathy Wyvill, RN, Karen Aleman, RN, Denise Whitby, PhD, Seth Steinberg, PhD, Giovanna Tosato, MD, Stefania Pittaluga, MD, Elaine S. Jaffe, MD, Robert Yarchoan, MD, Richard F. Little, MD

Blood (2007) 110 (11): 514.

https://doi.org/10.1182/blood.V110.11.514.514

Published: 2007

Journal Articles

Impact of IL-10 Polymorphisms in Survival of Lymphoid Neoplasms.

Eva Domingo-Domenech, Yolanda Benavente, Eva Gonzalez-Barca, Carlos Montalban, Josep Guma, Sophia S. Wang, Denise Whitby, Alberto Fernandez de Sevilla, Nathaniel Rothman, Silvia de Sanjose

Blood (2006) 108 (11): 2382.

https://doi.org/10.1182/blood.V108.11.2382.2382

Published: 2006

Journal Articles

Azidothymidine inhibits NF-κB and induces Epstein-Barr virus gene expression in Burkitt lymphoma

Motoki Kurokawa, Subrata K. Ghosh, Juan Carlos Ramos, Abdul M. Mian, Ngoc L. Toomey, Lisa Cabral, Denise Whitby, Glen N. Barber, Dirk P. Dittmer, William J. Harrington, Jr

Blood (2005) 106 (1): 235–240.

https://doi.org/10.1182/blood-2004-09-3748

Published: 2005

NARROW

Inflammasome activation in patients with Kaposi sarcoma herpesvirus–associated diseases

Treatment Outcomes and Prognostic Factors in 40 Patients with Primary Effusion Lymphoma

Phase I Study of Lenalidomide Combined with Dose-Adjusted EPOCH and Rituximab (EPOCH-R 2 ) in Primary Effusion Lymphoma in Participants with or without HIV (NCT02911142)

Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus–associated multicentric Castleman disease

Phase I/II Study of Lenalidomide Combined with DA-EPOCH and Rituximab (DA-EPOCH-R 2 ) in Primary Effusion Lymphoma in Patients with or without HIV

Viral, immunologic, and clinical features of primary effusion lymphoma

IL-13 Expression Characterizes Effusions Associated with Primary Effusion Lymphoma but Not Other Disorders Caused By Kaposi Sarcoma Herpesvirus (KSHV)

Pilot Study of Tocilizumab in Patients with HIV and Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease

Targeting HGF/c-MET induces cell cycle arrest, DNA damage, and apoptosis for primary effusion lymphoma

Inflammatory Cytokines, Hyperferritinemia and IgE Are Prognostic in Patients with KSHV-Associated Lymphomas Treated with Curative Intent Therapy

Pomalidomide Induces Expansion of Activated and Central Memory CD4+ and CD8+ T Cells in Vivo in Patients with and without HIV Infection

Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease

Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease

Clinical, Immunologic, and Virologic Findings in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Lymphomas Suggest KSHV-Associated Inflammatory Syndromes Contribute to Symptoms and Disease Pathogenesis.

EBV Copy Number Variation in Twins Discordant for Young Adult Hodgkin Lymphoma

Distinct Human and Viral Interleukin-6 Profiles and Other Viral and Immunologic Abnormalities In KSHV-Associated Multicentric Castleman Disease: Relationship with Disease Activity and Individual Disease Manifestations

High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy

Early Results of a Clinical Trial Using Targeted Oncolytic Virotherapy in Kaposi Sarcoma Herpes Virus (KSHV) Associated Multicentric Castleman’s Disease (MCD).

Impact of IL-10 Polymorphisms in Survival of Lymphoid Neoplasms.

Azidothymidine inhibits NF-κB and induces Epstein-Barr virus gene expression in Burkitt lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only